Currently set to Index
Currently set to Follow

Science Intravenous insulin therapy

The effect of insulin pump therapy in the retinal vasculature in type 1 diabetic patients
November 7, 2021
0
0
Main idea: We found that CSII provided better metabolic control than MDI and this seemed to result in higher parafoveal vascular density. As lower vascular density is associated with an increased risk of diabetic retinopathy, these results suggest that CSII could be the safest therapeutic option to prevent retinopathy. Abstract Continuous subcutaneous insulin infusion (CSII) is […]
Read more
Continuous Subcutaneous Insulin Infusions vs. Multiple Daily Injections of Insulin in Hospitalized Patients: Glycemic Trends in the First 24 Hours of Admission
November 7, 2021
0
0
Main ideas: Children treated with T1DM have a better control of blood glucose than those treated with MDI, and children and their family members are satisfied with continuous subcutaneous insulin infusion treatment. Therefore, it holds promise for clinical application. Abstract Background: Continuous subcutaneous insulin infusion (CSII) is a common diabetes treatment modality. Glycemic outcomes of patients using […]
Read more
Long-term follow-up of efficacy of insulin pump in the treatment of children with type 1 diabetes mellitus
November 7, 2021
0
0
Abstract The objective of the study wasto examine the clinical effect of continuous subcutaneous insulin infusion versus multiple daily injections (MDI) on blood glucose control in children with type 1 diabetes mellitus (T1DM). A retrospective analysis was performed on the medical data of 91 children with T1DM who were treated with continuous subcutaneous insulin infusion […]
Read more
Improved postprandial glucose control with ultra-rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2
November 7, 2021
0
0
Main idea: URLi was efficacious, providing superior PPG control and less time in hypoglycemia but with more frequent infusion-site reactions compared with lispro when administered by CSII. Abstract The aim of the study was to evaluate the efficacy and safety of ultra-rapid lispro (URLi) versus lispro (Humalog®) in people with type 1 diabetes on continuous subcutaneous […]
Read more
Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system
November 7, 2021
0
0
Main idea: Omnipod System use was associated with statistically and clinically meaningful reductions in Hemoglobin A1c(HbA1c)e A1c(HbA1c), TDD, and HE compared to prior treatments in T2DM. Abstract To compare glycemic outcomes in adults with type 2 diabetes mellitus (T2DM) before and 90 days after initiating Omnipod® or Omnipod DASH® Insulin Management Systems. In this retrospective observational […]
Read more
Longevity of the Novel ConvaTec Infusion Set with Lantern Technology
November 7, 2021
0
0
Abstract Current insulin infusion sets are approved for only 2-3 days. The novel ConvaTec infusion set with Lantern Technology is designed to extend infusion set wear time. The goal of this pilot study was to evaluate the duration of the wear time for this set. It was a pilot safety study in adults with type […]
Read more
Intravenous Insulin Therapy. Brief introduction
November 7, 2021
0
0
Intravenous insulin therapy is a treatment procedure aimed to manage high blood sugar (hyperglycemia) with intravenous infusion of insulin. Intravenous insulin is administered only in a hospital ICU setting in selected critically ill patients with a diabetes emergency or in other conditions affecting blood sugar who require rapid and efficient control of hyperglycemia. Self-administration of […]
Read more
A prospective randomized trial comparing computerized columnar insulin dosing chart (the Atlanta protocol) versus the joint British diabetes societies for inpatient care protocol in the management of hyperglycemia in patients with acute coronary syndrome admitted to cardiac care unit in Alexandria, Egypt
November 7, 2021
0
0
Main idea: Both protocols successfully maintained target BG level with a low incidence of clinically significant hypoglycemia, however, the computerized Atlanta protocol had better glycemic outcomes. We recommend the use of the computerized Atlanta protocol in CCU rather than JBDS for Inpatient Care Protocol whenever this is feasible. Abstract Hyperglycemia in acute coronary syndrome (ACS) is […]
Read more
Analysis of perioperative glucose metabolism using an artificial pancreas
November 7, 2021
0
0
Abstract Hyperglycemia associated with insulin resistance is common in surgical patients with and without diabetes and is associated with poor surgical outcomes. Several studies have recently shown that a closed-loop blood glucose monitoring system in the form of an artificial pancreas is safe and effective for surgical patients. In this study, we analyzed the risk […]
Read more
Clinical approaches to treat impaired awareness of hypoglycemia
November 7, 2021
0
0
Main idea: No single approach can be advocated for all patients, and it is the responsibility of the health care professional to identify the clinical strategy that best enables their patient to achieve this goal. Abstract Impaired awareness of hypoglycemia (IAH) affects between 25% and 30% of all people with type 1 diabetes (T1D) and markedly […]
Read more